These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 18465769)

  • 1. Rescue of cytotoxic function in the CD8alpha knockout mouse by removal of MHC class II.
    Riddle DS; Miller PJ; Vincent BG; Kepler TB; Maile R; Frelinger JA; Collins EJ
    Eur J Immunol; 2008 Jun; 38(6):1511-21. PubMed ID: 18465769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8 expression up to the double-positive CD3(low/intermediate) stage of thymic differentiation is sufficient for development of peripheral functional cytotoxic T lymphocytes.
    Zhang XL; Zhao S; Borenstein SH; Liu Y; Jayabalasingham B; Chamberlain JW
    J Exp Med; 2001 Sep; 194(5):685-93. PubMed ID: 11535636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-specific, CD8+ major histocompatibility complex class I-restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus-infected beta2-microglobulin-deficient mice.
    Quinn DG; Zajac AJ; Hioe CE; Frelinger JA
    J Virol; 1997 Nov; 71(11):8392-6. PubMed ID: 9343195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo.
    Lee RS; Grusby MJ; Glimcher LH; Winn HJ; Auchincloss H
    J Exp Med; 1994 Mar; 179(3):865-72. PubMed ID: 8113680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting edge: MHC class II-restricted killing in vivo during viral infection.
    Jellison ER; Kim SK; Welsh RM
    J Immunol; 2005 Jan; 174(2):614-8. PubMed ID: 15634878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice.
    Muller D; Koller BH; Whitton JL; LaPan KE; Brigman KK; Frelinger JA
    Science; 1992 Mar; 255(5051):1576-8. PubMed ID: 1347959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
    Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
    Matloubian M; Concepcion RJ; Ahmed R
    J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
    Dalloul AH; Ngo K; Fung-Leung WP
    Eur J Immunol; 1996 Jan; 26(1):213-8. PubMed ID: 8566069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha beta TCRs differ in the degree of their specificity for the positively selecting MHC/peptide ligand.
    Kraj P; Pacholczyk R; Ignatowicz L
    J Immunol; 2001 Feb; 166(4):2251-9. PubMed ID: 11160279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for accessibility to self-peptide-self-MHC complexes in intrathymic negative selection.
    Viret C; Sant'Angelo DB; He X; Ramaswamy H; Janeway CA
    J Immunol; 2001 Apr; 166(7):4429-37. PubMed ID: 11254698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The virus-specific and allospecific cytotoxic T-lymphocyte response to lymphocytic choriomeningitis virus is modified in a subpopulation of CD8(+) T cells coexpressing the inhibitory major histocompatibility complex class I receptor Ly49G2.
    Peacock CD; Lin MY; Ortaldo JR; Welsh RM
    J Virol; 2000 Aug; 74(15):7032-8. PubMed ID: 10888642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo treatment of class II MHC-deficient mice with anti-TCR antibody restores the generation of circulating CD4 T cells and optimal architecture of thymic medulla.
    Nasreen M; Ueno T; Saito F; Takahama Y
    J Immunol; 2003 Oct; 171(7):3394-400. PubMed ID: 14500633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymus leukemia antigen (TL)-specific cytotoxic T lymphocytes recognize the alpha1/alpha2 domain of TL free from antigenic peptides.
    Tsujimura K; Obata Y; Kondo E; Nishida K; Matsudaira Y; Akatsuka Y; Kuzushima K; Takahashi T
    Int Immunol; 2003 Nov; 15(11):1319-26. PubMed ID: 14565930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locally superantigen-activated peritoneal cytolytic T lymphocytes belong to the CD8+ CD45RC- subset and lyse MHC class II+ tumor cells.
    Hansson J; Ericsson PO; Dohlsten M; Sjögren HO; Kalland T; Hedlund G
    Immunol Lett; 1992 Dec; 34(3):229-36. PubMed ID: 1487309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR7 expression in developing thymocytes is linked to the CD4 versus CD8 lineage decision.
    Yin X; Ladi E; Chan SW; Li O; Killeen N; Kappes DJ; Robey EA
    J Immunol; 2007 Dec; 179(11):7358-64. PubMed ID: 18025179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular marker for thymocyte-positive selection: selection of CD4 single-positive thymocytes with shorter TCRB CDR3 during T cell development.
    Yassai M; Ammon K; Goverman J; Marrack P; Naumov Y; Gorski J
    J Immunol; 2002 Apr; 168(8):3801-7. PubMed ID: 11937532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-positive selection of thymocytes expressing a single TCR by multiple major histocompatibility complex molecules of both classes: implications for CD4+ versus CD8+ lineage commitment.
    Eshima K; Suzuki H; Shinohara N
    J Immunol; 2006 Feb; 176(3):1628-36. PubMed ID: 16424192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.